Pfizer discusses anti-smoking drug in new ad and PR campaign
Pfizer plans to use PR and advertising to bolster support for its antismoking drug Chantix, in the wake of concerns regarding the drug's effectiveness at safe dosage levels, the Wall Street Journal reported.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.